ROYALTY PHARMA PLC shareholders Q2 2023

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.

ROYALTY PHARMA PLC shareholders Q2 2023
NameSharesValueWeighting ↓
Transamerica Financial Advisors, Inc. 12,027$3700.05%
Point72 Asset Management, L.P. 530,200$16,298,3480.05%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 2,490,414$76,555,3260.04%
JANUS HENDERSON GROUP PLC 2,274,100$69,905,3490.04%
Koshinski Asset Management, Inc. 12,900$396,5460.04%
Squarepoint Ops LLC 435,330$13,382,0440.04%
GSA CAPITAL PARTNERS LLP 12,779$3930.04%
LOS ANGELES CAPITAL MANAGEMENT LLC 305,366$9,386,9510.04%
Teza Capital Management LLC 13,399$411,8850.04%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 1,358,304$41,754,2650.04%
Hillsdale Investment Management Inc. 12,800$393,4720.04%
USS Investment Management Ltd 100,113$3,076,4720.04%
FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND 88,950$2,7340.03%
Renaissance Technologies 770,700$23,6910.03%
Leucadia National 118,730$3,649,7600.03%
SYNOVUS FINANCIAL CORP 95,020$2,920,9160.03%
DekaBank Deutsche Girozentrale 473,981$14,4080.03%
Park Place Capital Corp 3,717$114,2610.03%
Point72 Middle East FZE 38,059$1,169,9310.03%
PRELUDE CAPITAL MANAGEMENT, LLC 15,944$490,1190.03%
External links

This page lists ROYALTY PHARMA PLC's shareholders in Q2 2023. To view ROYALTY PHARMA PLC's shareholder history, click here.